Who are Acid Reflux Relief's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Potassium Iodide, Micro-K 10, IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER, potassium bromide, Ilaris, Apokyn.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/sodium-phosphates-in-plastic-container.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Acid Reflux Relief — Competitive Intelligence Brief

Acid Reflux Relief (Sodium Phosphate, Dibasic, Heptahydrate) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Non-Standardized Plant Allergenic Extract [EPC].

marketed Non-Standardized Plant Allergenic Extract [EPC] Carbonic anhydrase 4 Live · refreshed every 30 min

Target snapshot

Acid Reflux Relief (Sodium Phosphate, Dibasic, Heptahydrate) — Pfizer.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Acid Reflux Relief TARGET	Sodium Phosphate, Dibasic, Heptahydrate	Pfizer	marketed	Non-Standardized Plant Allergenic Extract [EPC]	Carbonic anhydrase 4	1983-01-01
Potassium Iodide	POTASSIUM IODIDE	Roxane	marketed		Carbonic anhydrase 4	1979-01-01
Micro-K 10	POTASSIUM CHLORIDE	Nesher Pharms	marketed	potassium chloride	Carbonic anhydrase 4	1965-01-01
IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM PHOSPHATE, MONOBASIC ANHYDROUS	OTSUKA ICU MEDCL	marketed		Carbonic anhydrase 4
potassium bromide	potassium bromide		marketed		Carbonic anhydrase 4
Ilaris	CANAKINUMAB	Novartis Pharms	marketed	Non-Standardized Plant Allergenic Extract [EPC]	Interleukin-1 beta	2009-01-01
Apokyn	APOMORPHINE	Mdd Us	marketed	Non-Standardized Plant Allergenic Extract [EPC]	D(2) dopamine receptor	2004-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2028-06-22 — Acid Reflux Relief · 7687075 · US
2039-03-07 — Micro-K 10 · 12539314 · Formulation · US

Sponsor landscape (Non-Standardized Plant Allergenic Extract [EPC] class)

· 4 drugs in this class
BioNTech · 2 drugs in this class
Dey · 1 drug in this class
Fudan University · 1 drug in this class
Green Cross Corporation · 1 drug in this class
Mdd Us · 1 drug in this class
Merck · 1 drug in this class
National Cancer Institute (NCI) · 1 drug in this class
National Center for Complementary and Integrative Health (NCCIH) · 1 drug in this class
Novartis Pharmaceuticals · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Acid Reflux Relief — Competitive Intelligence Brief. https://druglandscape.com/ci/sodium-phosphates-in-plastic-container. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab